ENTITY
Celltrion Inc

Celltrion Inc (068270 KS)

509
Analysis
Health CareSouth Korea
Celltrion Inc. produces and sells biosimilar products and also provides consignm ent processing service for other companies. The Company's main product is Abata cept which is for arthritis treatment
more
bearishOrigin Energy
04 Dec 2023 00:11

Merger Arb Mondays (4 Dec) - Origin, OreCorp, Healius, CIMC Vehicles, T&K Toka, Eoflow, Hollysys

This week, the highest gross spreads are Eoflow (215.5%), 111 (93.7%), IRC (22.9%), OreCorp (20.8%), Healius (18.7%), Hollysys (15.5%), Origin...

Logo
1.1k Views
Share
01 Dec 2023 08:51

(Mostly) Asia M&A, Nov 2023: Taisho Pharma, CIMC Vehicle, CMIC, Japan Best Rescue, Shidax

For the month of November, 16 new deals were discussed on Smartkarma with an overall deal size of ~US$13bn. The average premium for the new deals...

Logo
495 Views
Share
29 Nov 2023 13:39

Spread Trade Opportunities Arising from KQ150/KS200 Passive Flows in the Celltrion Merger

This post delves into the detailed implications of the Celltrion merger on KOSPI 200/KOSDAQ 150 passive flows. It's crucial, as the widening swap...

Logo
506 Views
Share
bearishOrigin Energy
27 Nov 2023 00:18

Merger Arb Mondays (27 Nov) - Origin, OreCorp, Healius, Taisho, JSR, Eoflow, Hollysys, Haitong Intl

This week, the highest gross spreads are Eoflow (218%), 111 (69.4%), Taisho Pharma (55.5%), Healius (48.0%), IRC (20.4%), Hollysys (12.8%), Origin...

Logo
592 Views
Share
23 Nov 2023 18:52

KOSDAQ150 Index Rebalance: 17 Changes a Side; Many Surprises

There are 17 changes a side for the KOSDAQ150 in Dec. Most of the inclusions were on expected lines, but there are many difference among the...

Logo
534 Views
Share
x